Andrew K. Reilly – As the Interim President and Chief Executive Officer, Mr. Reilly is responsible for the company's overall strategy and daily operations. Andrew is also the Managing Director of Thomas Keenan Ventures (TKV), the majority owner of WoundTEK, Inc. Prior to founding TKV, Andrew co-founded and lead as CEO; an enterprise software company which was venture backed and then sold 13 months after its inception to a publicly held company based in London for $3.8 Million. Mr Reilly also founded a data storage services business, ITIS Services, also venture backed, that was sold to a publicly traded US company for $21.6 Million in December of 2001. Prior to ITIS Services Mr. Reilly held several positions at EMC Corporation from 1993 through 1998. Andrew earned a bachelor of arts degree from Boston College in 1991.

Martin Knopf – Mr. Knopf has 32 years of experience in the life sciences sector. He spent 17 years at Johnson & Johnson in positions of increasing responsibility in a number of their operating companies. In his most recent position with Johnson & Johnson, he served as Worldwide Business Development Director at Ethicon. He has also served as EVP of Corporate Development & U.S. General Manager of OMRIX biopharmaceuticals, VP Business Development at HydroCision and COO of Hi-Tech Pharmacal.

James Lousararian – Mr. Lousararian is the Chief Executive Officer of Verax Biomedical. Prior to joining Verax, James was a consultant for Medtronic Vascular following Medtronic's acquisition of Angiolink Corporation in November 2004. Mr. Lousararian was the President and CEO, as well as a Director and co-Founder of AngioLink, a life sciences start-up in the fields of wound management and interventional cardiology. Prior to the founding of AngioLink in late 1999, Mr. Lousararian was Senior Vice President and Chief Operating Officer of STD Manufacturing Inc., a medical device OEM manufacturer. Prior to joining STD, Mr. Lousararian was Vice President of Thermo ReTec Corp., an American Stock Exchange company and part of the Thermo Electron family of companies, where Mr. Lousararian was President of two major subsidiaries and responsible for business development. Mr. Lousararian is also a co-founder of ArthroSurface Incorporated, a start-up orthopedics company and Spirus Medical, Inc., a start-up medical device company in the gastroenterology and urology fields.

Dave Johnson – Dave is currently the Vice President of Global Sales and Marketing for American Power Conversion the leading provider of hardware and software designed to protectcomputer, networking, and storage equipment for both business and consumerapplications with annual revenues exceeding $2 billion. He leads APC’s regional and global teams with staff of approximately 2000 people. Dave has served as Vice President of the Americas leading the sales and marketing of APC solutions in North and Latin America where he was responsible for revenue in excess of $1 billion annually. Johnson also served as general manager, APC Rack Systems, a $200 million product division of APC. Since joining APC in1989, Dave has held multiple product management, sales management andgeneral management positions. Dave began his career with GE Plastics, serving as a financial analyst from1986 to 1989. Johnson has a BS in Economics from Cornell University. He is married with three children and resides in Middletown, RI.

David LaSalle – David LaSalle is currently the Vice President of Operations of Omni Life Science Corporation. Prior to Omni Life Science, Mr. LaSalle founded and was the Managing Director of Apex Surgical, a manufacturer of total hip replacement devices. David founded Apex in 1999 and was responsible for its day-to-day operations and overall strategy until its sale to Omni Life Sciences in 2005. Prior to Apex, Mr. LaSalle worked in many management positions at Johnson & Johnson where he won numerous awards for his achievement and was responsible for several medical device patents during his employment. Mr. LaSalle is a graduate of the Bryant College school of Business where he received his MBA and of New England Technical Institute where he received his degree in product design and engineering. David has been very involved in his community serving on many charitable committees and as a member of the town planning and budget committee of North Smithfield, RI.

Gen. Randall Bell MD – General Bell is a highly decorated retired General of the US Army. He is responsible for directing WoundTEK through the US government Defense and Veterans Organizations to help market and sell The S.T.A.R. device. The Military Health System (MHS) is comprised of 330 hospitals and 500 medical centers world wide, while the Veterans Administration operates of 20 hospitals in the United States, this is a key area of concentration for the company’s growth strategy in 2005 and 2006. Prior to WoundTEK General Bell has held many roles as director to various organizations including a long directorship at The West Point Military Academy.